Copper-Catalyzed Oxydifluoroalkylation of β,γ-Unsaturated Oximes for the Construction of Isoxazolines with a Difluoroalkyl Side Chain

Lianxin Wang; Hongtai Chen; Wentao Zhao; Guangwei Wang

doi:10.1055/a-1495-7966

Synlett, Table of Contents

Synlett 2021; 32(10): 1029-1033
DOI: 10.1055/a-1495-7966

letter

Copper-Catalyzed Oxydifluoroalkylation of β,γ-Unsaturated Oximes for the Construction of Isoxazolines with a Difluoroalkyl Side Chain

Lianxin Wang

,

Hongtai Chen

,

Wentao Zhao

,

Guangwei Wang ∗

Abstract

All articles of this category

Abstract

A copper-catalyzed oxydifluoroalkylation of β,γ-unsaturated oximes has been developed. This reaction proceeded through a cascade of difluoroalkylation of alkene followed by a nucleophilic attack of the hydroxyl group of oximes. This protocol features mild reaction conditions, low-cost catalyst, and broad substrate scope, which provides a facile method to synthesize isoxazolines with a fluorinated side chain

Key words

copper-catalyzed - oxydifluoroalkylation - isoxazoline - oximes - radical cyclization

Full Text

References

References and Notes

1a Kozikowski AP. Acc. Chem. Res. 1984; 17: 410
1b Kaur K, Kumar V, Sharma AK, Gupta GK. Eur. J. Med. Chem. 2014; 77: 121
1c Puttaswamy N, Kumar GS. P, Al-Ghorbani M, Vigneshwaran V, Prabhakar BT, Khanum SA. Eur. J. Med. Chem. 2016; 114: 153
1d Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, Lahm GP, Long JK, Xu M, Wagerle T, Jones GS, Dietrich RF, Cordova D, Schroeder ME, Rhoades DF, Benner EA, Confalone PN. Vet. Parasitol. 2014; 201: 179
1e Castellano S, Kuck D, Viviano M, Yoo J, Lopez-Vallejo F, Conti P, Tamborini L, Pinto A, Medina-Franco JL, Sbardella G. J. Med. Chem. 2011; 54: 7663
1f Ismail T, Shafi S, Singh S, Sidiq T, Khajuria A, Rouf A, Yadav M, Saikam V, Singh PP, Alam MS, Islam N, Sharma K, Kumar HM. S. Eur. J. Med. Chem. 2014; 123: 90
1g Xue C.-B, Wityak J, Sielecki TM, Pinto DJ, Batt DG, Cain GA, Sworin M, Rockwell AL, Roderick JJ, Wang S, Orwat MJ, Frietze WE, Bostrom LL, Liu J, Higley CA, Rankin FW, Tobin AE, Emmett G, Lalka GK, Sze JY, Meo SV. D, Mousa SA, Thoolen MJ, Racanelli AL, Hausner EA, Reilly TM, DeGrado WF, Wexler RR, Olson RE. J. Med. Chem. 1997; 40: 2064
1h Wityak J, Sielecki TM, Pinto DJ, Emmett G, Sze JY, Liu J, Tobin AE, Wang S, Jiang B, Ma P, Mousa SA, Wexler RR, Olson RE. J. Med. Chem. 1997; 40: 50
1i Antczak C, Bauvois B, Monnereta C, Florent J.-C. Bioorg. Med. Chem. 2001; 9: 2843
1j Olson RE, Sielecki TM, Wityak J, Pinto DJ, Batt DG, Frietze WE, Liu J, Tobin AE, Orwat MJ, Meo SV. D, Houghton GC, Lalka GK, Mousa SA, Racanelli AL, Hausner EA, Kapil RP, Rabel SR, Thoolen MJ, Reilly TM, Anderson PS, Wexler RR. J. Med. Chem. 1999; 42: 1178
1k Xiang Y, Chen J, Schinazi RF, Zhao K. Bioorg. Med. Chem. Lett. 1996; 6: 1051

2a Tang S, He J, Sun Y, He L, She X. J. Org. Chem. 2010; 75: 1961
2b Bode JW, Carreira EM. Org. Lett. 2001; 3: 1587
2c Fuller AA, Chen B, Minter AR, Mapp AK. J. Am. Chem. Soc. 2005; 127: 5376
2d Minter AR, Fuller AA, Mapp AK. J. Am. Chem. Soc. 2003; 125: 6846
2e Bode JW, Carreira EM. J. Org. Chem. 2001; 66: 6410
2f Marotta E, Micheloni LM, Scardovi N, Righi P. Org. Lett. 2001; 3: 727

3a Arai MA, Arai T, Sasai H. Org. Lett. 1999; 1: 1795
3b Tsujihara T, Shinohara T, Takenaka K, Takizawa S, Onitsuka K, Hatanaka M, Sasai H. J. Org. Chem. 2009; 74: 9274
3c Muthiah C, Arai MA, Shinohara T, Arai T, Takizawa S, Sasai H. Tetrahedron Lett. 2003; 44: 5201

4a Adamo MF. A, Nagabelli M. Org. Lett. 2008; 10: 1807
4b Li C, Deng H, Li C, Jia X, Li J. Org. Lett. 2015; 17: 5718
4c Schmidt EY, Tatarinova IV, Ivanova EV, Zorina NV, Ushakov IA, Trofimov BA. Org. Lett. 2013; 15: 104
4d Norman AL, Shurrush KA, Calleroz AT, Mosher MD. Tetrahedron Lett. 2007; 48: 6849
4e Bode JW, Fraefel N, Muri D, Carreira EM. Angew. Chem. Int. Ed. 2001; 40 2082
4f Minakata S, Okumura S, Nagamachi T, Takeda Y. Org. Lett. 2011; 13: 2966
4g Han L, Zhang B, Zhu M, Yan J. Tetrahedron Lett. 2014; 55: 2308
4h Das B, Holla H, Mahender G, Banerjee J, Reddy MR. Tetrahedron Lett. 2004; 45: 7347
4i Li X, Wang X, Wang Z, Yan X, Xu X. ACS Sustainable Chem. Eng. 2019; 7: 1875
4j Tripathi CB, Mukherjee S. Angew. Chem. Int. Ed. 2013; 52: 8450
4k Zhang X.-W, Xiao Z.-F, Wang M.-M, Zhuang Y.-J, Kang Y.-B. Org. Biomol. Chem. 2016; 14: 7275
4l Mosher MD, Norman AL, Shurrush KA. Tetrahedron Lett. 2009; 50: 5647
4m Hu X.-Q, Chen J, Chen J.-R, Yan D.-M, Xiao W.-J. Chem. Eur. J. 2016; 22: 14141
4n Triandafillidi I, Kokotos CG. Org. Lett. 2017; 19: 106
4o Yu J.-M, Cai C. Org. Biomol. Chem. 2018; 16: 490
4p Yu W, Yang S, Wang P.-L, Li P, Li H. Org. Biomol. Chem. 2020; 18: 7165
4q Zhang X.-W, Xiao Z.-F, Zhuang Y.-J, Wang M.-M, Kang Y.-B. Adv. Synth. Catal. 2016; 358: 1942

5a Dong K.-Y, Qin H.-T, Liu F, Zhu C. Eur. J. Org. Chem. 2015; 1419
5b Zhu M.-K, Zhao J.-F, Loh T.-P. J. Am. Chem. Soc. 2010; 132: 6284
5c Dong K.-Y, Qin H.-T, Bao X.-X, Liu F, Zhu C. Org. Lett. 2014; 16: 5266
5d Jiang D, Peng J, Chen Y. Org. Lett. 2008; 10: 1695
5e Norman AL, Mosher MD. Tetrahedron Lett. 2008; 49: 4153

6a Ji F, Fan Y, Yang R, Yang Y, Yu D, Wang M, Li Z. Asian J. Org. Chem. 2017; 6: 682
6b Yu W, Wang P.-L, Xu K, Li H. Asian J. Org. Chem. 2021; 10: 1

7a Liu R.-H, Wei D, Han B, Yu W. ACS Catal. 2016; 6: 6525
7b Wang L.-J, Chen M, Qi L, Xu Z, Li W. Chem. Commun. 2017; 53: 2056
7c Meng F, Zhang H, Guo K, Dong J, Lu A.-M, Zhu Y. J. Org. Chem. 2017; 82: 10742
7d Zhu L, Yu H, Xu Z, Jiang X, Lin L, Wang R. Org. Lett. 2014; 16: 1562
7e Han W.-J, Wang Y.-R, Zhang J.-W, Chen F, Zhou B, Han B. Org. Lett. 2018; 20: 2960
7f Li X.-T, Gu Q.-S, Dong X.-Y, Meng X, Liu X.-Y. Angew. Chem. Int. Ed. 2018; 57: 7668

8 Li W, Jia P, Han B, Li D, Yu W. Tetrahedron 2013; 69: 3274
9 Jimoh AA, Hosseyni S, Ye X, Wojtas L, Hu Y, Shi X. Chem. Commun. 2019; 55: 8150
10 O’Hagan D. Chem. Soc. Rev. 2008; 37: 308
11 Zhu L, Wang G, Guo Q, Xu Z, Zhang D, Wang R. Org. Lett. 2014; 16: 5390

12a Zhang W, Su Y, Wang K.-H, Wu L, Chang B, Shi Y, Huang D, Hu Y. Org. Lett. 2017; 19: 376
12b He Y.-T, Li L.-H, Yang Y.-F, Wang Y.-Q, Luo J.-Y, Liu X.-Y, Liang Y.-M. Chem. Commun. 2013; 49: 5687
12c Wei Q, Chen J.-R, Hu X.-Q, Yang X.-C, Lu B, Xiao W.-J. Org. Lett. 2015; 17: 4464

13 Zhu M, Fun W, Guo W, Tian Y, Wang Z, Xu C, Ji B. Eur. J. Org. Chem. 2019; 1614

14a Kong W, Guo Q, Xu Z, Wang G, Jiang X, Wang R. Org. Lett. 2015; 17: 3686
14b Zhao J, Jiang M, Liu J.-T. Adv. Synth. Catal. 2017; 359: 1626
14c Liu Y.-Y, Yang J, Song R.-J, Li J.-H. Adv. Synth. Catal. 2014; 356: 2913

15a Wang X, Zhao S, Liu J, Zhu D, Guo M, Tang X, Wang G. Org. Lett. 2017; 19: 4187
15b Chen H, Wang X, Guo M, Zhao W, Tang X, Wang G. Org. Chem. Front. 2017; 4: 2403
15c Li Y, Liu J, Zhao S, Du X, Guo M, Zhao W, Tang X, Wang G. Org. Lett. 2018; 20: 917
15d Feng X, Wang X, Chen H, Tang X, Guo M, Zhao W, Wang G. Org. Biomol. Chem. 2018; 16: 2841
15e Wang X, Li M, Yang Y, Guo M, Tang X, Wang G. Adv. Synth. Catal. 2018; 360: 2151
15f Wang X, Liu J, Yu Z, Guo M, Tang X, Wang G. Org. Lett. 2018; 20: 6516

16a Yuan F, Zhou S, Yang Y, Guo M, Tang X, Wang G. Org. Chem. Front. 2018; 5: 3306
16b Yang Y, Yuan F, Ren X, Wang G, Zhao W, Tang X, Guo M. J. Org. Chem. 2019; 84: 4507

17a Chen F, Zhu F.-F, Zhang M, Liu R.-H, Yu W, Han B. Org. Lett. 2017; 19: 3255
17b Xu Z.-Q, Zheng L.-C, Li L, Duan L, Li Y.-M. Org. Biomol. Chem. 2019; 17: 898

18 Copper-Catalyzed Oxydifluoroalkylation of β,γ-Unsaturated Oximes: Typical Procedure To a 25 mL of Schlenk tube was added CuI (19.0 mg, 0.1 mmol), Na₂S₂O₅ (38.0 mg, 0.2 mmol), NaHCO₃ (126.0 mg, 1.5 mmol), and 1-phenylbut-3-en-1-one oxime (161.2 mg, 1.0 mmol) under Ar atmosphere. DMSO (2.0 mL), PMDETA (42 μL, 0.2 mmol), and ethyl bromodifluoroacetate (192 μL, 1.5 mmol) were added subsequently. The reaction mixture was stirred at 110 °C (oil bath) for 12 h. After completion by TLC detection, the reaction mixture was cooled to room temperature and quenched with water and ethyl acetate. The combined organic extracts were washed with brine, dried over anhydrous Na₂SO₄, and concentrated in vacuo. The crude product was purified with silica gel chromatography (petroleum ether/ethyl acetate = 10:1) to give 3aa (198 mg, 70% yield) as a light-yellow solid. Ethyl 2,2-Difluoro-3-(3-phenyl-4,5-dihydroisoxazol-5-yl)propanoate (3aa) Mp 87.4–91.7 °C. ¹H NMR (400 MHz, CDCl₃): δ = 7.68–7.62 (m, 2 H), 7.43–7.35 (m, 3 H), 5.02–4.91 (m, 1 H), 4.36 (q, J = 7.2 Hz, 2 H), 3.52 (dd, J = 16.7, 10.3 Hz, 1 H), 3.12 (dd, J = 16.7, 7.7 Hz, 1 H), 2.46–2.31 (m, 1 H), 2.77–2.60 (m, 1 H), 1.37 (t, J = 7.2 Hz, 3 H). ¹³C NMR (101 MHz, CDCl₃): δ = 163.6 (t, ² J _C–F = 32.0 Hz), 156.7, 130.4, 129.2, 128.9, 126.8, 114.7 (t, ¹ J _C–F = 252.48 Hz), 75.0 (dd, ³ J _C–F = 6.2, 3.2 Hz), 63.3, 40.7, 40.0 (t, ² J _C–F = 22.9 Hz), 14.0. ¹⁹F NMR (376 MHz, CDCl₃): δ = –102.58 (ddd, J = 264.1, 16.0, 11.5 Hz, 1 F), –106.96 (ddd, J = 264.0, 19.2, 17.6 Hz, 1 F). HRMS (ESI): m/z [M + H]⁺ calcd for C₁₄H₁₆NO₃F₂ ⁺: 284.1093; found: 284.1102. N-Butyl-2,2-difluoro-3-(5-phenyl-3,4-dihydro-2H-pyrrol-3-yl)propanamide (3ab) This compound was prepared according to the typical procedure and purified with silica gel chromatography (petroleum ether/ethyl acetate = 5:1) as a light-yellow solid (158.3 mg, 51% yield); mp 104.7–105.6 °C. ¹H NMR (600 MHz, CDCl₃): δ = 7.66–7.63 (m, 2 H), 7.42–7.38 (m, 3 H), 6.50 (s, 1 H), 5.01–4.95 (m, 1 H), 3.53 (dd, J = 16.6, 10.3 Hz, 1 H), 3.34 (q, J = 6.9 Hz, 2 H), 3.13 (dd, J = 16.6, 8.1 Hz, 1 H), 2.69–2.58 (m, 1 H), 2.56–2.45 (m, 1 H), 1.59–1.53 (m, 2 H), 1.41–1.34 (m, 2 H), 0.94 (t, J = 7.4 Hz, 3 H). ¹³C NMR (151 MHz, CDCl₃): δ = 163.7 (t, ² J _C–F = 27.9 Hz), 156.8, 130.4, 129.3, 128.9, 126.8, 116.7 (t, ¹ J _C–F = 253.4 Hz), 75.4 (t, ³ J _C–F = 4.0 Hz), 40.9, 39.6, 39.4 (t, ² J _C–F = 22.8 Hz), 31.3, 20.0, 13.8. ¹⁹F NMR (565 MHz, CDCl₃): δ = –103.64 (dt, J = 258.8, 17.3 Hz, 1 F), –104.64 (dt, J = 258.7, 16.4 Hz, 1 F). HRMS (ESI): m/z [M + H]⁺ calcd for C₁₆H₂₁N₂O₂F₂ ⁺: 311.1566; found: 311.1572.

Supplementary Material

Supporting Information